Communication

Implementation and support

It is essential to communicate the clinical and economic value of your product in a way that resonates with the many stakeholders in access and reimbursement decision-making. Our consultants and communication experts will guide you through reimbursement and health technology assessment (HTA) submissions process, where evidence and value determine access decisions. Our health economic modellers will quantify the financial benefits of product adoption, and our experienced digital team are world-leaders in developing engaging, interactive value communication tools for use with payers and clinicians.

Cross-market HTA/reimbursement submissions

In many key markets, gaining approval by national reimbursement, pricing or health technology assessment (HTA) agencies is critical to commercial success of a new product launch. Typically, companies need to prepare and submit comprehensive evidence dossiers and economic models to agencies, before negotiation on access conditions can begin. Successful submissions integrate clinical and economic messaging effectively, while presenting robust and transparent evidence summaries and economic models.

Our team of market access writers, health economists, literature review analysts, medical statisticians and consultants are experienced in preparing for HTA submissions, with over 100 years of collective HTA experience behind them. We can work collaboratively and guide you through the process, advise on your HTA strategy, and develop all you need for a robust submission.

Name / Name / Name

Value dossiers

Global value dossiers (GVDs) play an integral role in synchronising evidence and messaging for market access teams. These tools need to be robust and comprehensive, yet accessible and easy-to-read. However, in many cases these can be bloated, hard-to-use and, consequently, ignored by affiliates.

At Mtech Access, we understand the challenges involved with compiling message-centric evidence dossiers that work to support affiliates in their reimbursement negotiations. Our in-house team of market access writers are experienced in designing and developing GVDs. Their inherent knowledge of current health technology assessment requirements allows them to prepare dossiers that will work for the affiliates that need them, while also ensuring that core messaging is consistently communicated and substantiated.

We also offer interactive solutions to evidence engagement. Our team of developers work hand-in-hand with our writing and consulting team to develop bespoke, interactive solutions empowering global market access teams to manage their evidence and messaging, as well as allowing affiliates to build bespoke dossiers and slide decks.

Name / Name / Name

Budget impact models

Communicating the financial impact of your product to payers is a vital step in market access negotiations worldwide. However, very often these models can become overcomplicated and hard to use. At Mtech Access, our in-house health economics team are global leaders in developing budget impact models that communicate value clearly and transparently, facilitating effective payer negotiations.

Our process begins with understanding your evidence and commercial objectives, before laying out the “storyboard” of the model. This vital step allows us to ensure that the communication flow and use of evidence is optimised. Once agreed, we develop a fully functional Excel-based model. 

We believe using a budget impact model should be an enjoyable and engaging experience, for company representatives and payers alike. This is why many of our Excel-based models are converted to interactive Payer value toolkits, most often integrated within Veeva and delivered via iPad.

Name / Name / Name

Market-leading digital communication solutions

We live in a digital age. Payers expect data to be dynamic and customisable. Companies need to track field-force activity and return-on-investment at the click of a button. Our experienced digital team are world-leaders in developing engaging, interactive value communication tools for use with payers and clinicians.

Read more
Name / Name / Name

Publications

Formalising the presentation of key evidence and research for publication in academic journals and for presentation at conferences, can provide academic rigour to support your market access strategy. From cost-effectiveness and cost-impact studies through to network meta-analyses and systematic literature reviews, our team of market access writers will work with you to understand your commercial objectives and develop publications that meet both your and the journal/conference requirements. 

Name / Name / Name